Developmental Research Program
Developmental Research Program
批准号:
10218112
负责人:
Robert Daniel Beauchamp
金额:
$8.33万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-09 至 2024-05-31
关键词:
Advisory CommitteesAreaCancer CenterCollaborationsDataDevelopmentDisciplineEmerging TechnologiesExtramural ActivitiesFosteringFundingFunding MechanismsFutureGoalsGrantInstitutionK-Series Research Career ProgramsLeadLeadershipMalignant NeoplasmsMalignant neoplasm of gastrointestinal tractMinorityMissionNeoplasmsPilot ProjectsProceduresPublicationsResearchResearch PersonnelRewardsSystemTennesseeThe Vanderbilt-Ingram Cancer Center at the Vanderbilt UniversityTranslational ResearchUnderrepresented MinorityUnderrepresented PopulationsUnited States National Institutes of HealthUniversitiesWomanadvanced diseaseanticancer researchcareerdesigngastrointestinalhigh riskinnovationmedical schoolsmembernew technologynovelprograms
中文摘要
项目摘要/摘要:发展研究计划
范德比尔特-英格拉姆癌症中心发展研究计划 (DRP) 的总体目标
胃肠 (GI) 癌症中心 SPORE(以下简称 VICC GI SPORE)旨在鼓励创新
胃肠道肿瘤的转化研究。 DRP 将由一名董事(R. Daniel Beauchamp,医学博士)领导,并将
得到由高级研究人员组成的发展研究咨询委员会 (DRAC) 的支持
范德比尔特和梅哈里医学院 (MMC)。 DRP 领导层与职业有显着交叉
增强计划 (CEP) 领导层鼓励 CEP 接受者申请 DRP 资金并确定
DRP 为 CEP 有前途的研究人员。 VICC GI SPORE DRP 将使用既定且高度
向范德比尔特大学、MMC 和田纳西州立大学的调查人员征求申请的有效程序
大学。主任和 DRAC 还将积极征求目标调查员(女性)的申请
和代表性不足的少数族裔)在三个机构内。内部和外部研究人员,包括
GI SPORE 外部顾问委员会成员将使用 NIH 9 分评分来审查申请
系统。评审员将评估该项目的科学价值和支持当前 GI SPORE 的可能性
活动,带来外部资金,和/或带来未来的 GI SPORE 项目。将特别强调
吸引年轻研究者参与胃肠道癌症研究、高风险/高收益项目以及
整合新兴技术并将其应用于胃肠道癌症研究。因此,VICC GI SPORE DRP 将
提供新的研究方向的机会,这些方向可能具有更高的风险,但也有很大的机会
奖励,包括独立资助和可能构成下一次竞争基础的额外项目
更新。
英文摘要
PROJECT SUMMARY/ABSTRACT: Developmental Research Program
The overall objective of the Developmental Research Program (DRP) within the Vanderbilt-Ingram Cancer
Center SPORE in Gastrointestinal (GI) Cancer (hereafter, VICC GI SPORE) is to encourage innovative
translational research in GI neoplasia. The DRP will be led by a Director (R. Daniel Beauchamp, MD) and will
be supported by the Developmental Research Advisory Committee (DRAC) made up of senior investigators at
Vanderbilt and Meharry Medical College (MMC). The DRP leadership has significant crossover with the Career
Enhancement Program (CEP) leadership to encourage CEP recipients to apply for DRP funding and to identify
promising investigators from DRP for the CEP. The VICC GI SPORE DRP will use an established and highly
effective procedure to solicit applications from investigators at Vanderbilt, MMC, and Tennessee State
University. The Director and the DRAC will also actively solicit applications from targeted investigators (women
and underrepresented minorities) within the three institutions. Internal and external researchers, including
members of the GI SPORE External Advisory Board, will review applications using the NIH 9-point scoring
system. Reviewers will evaluate scientific merit and the likelihood of the project to support current GI SPORE
activities, lead to extramural funding, and/or lead to future GI SPORE projects. Special emphasis will be placed
on attracting young investigators into GI cancer research, high risk/high gain projects, and projects that
incorporate emerging technologies and apply them to GI cancer research. Thus, the VICC GI SPORE DRP will
offer the opportunity for new directions of study that may be of higher risk but also have a significant chance for
reward, including independent funding and additional projects that may form the basis of the next competing
renewal.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 3: Targeting MYC in CRC
-
批准号:10700857
-
项目类别:
-
资助金额:$31.76万
-
财政年份:2019
-
负责人:Robert Daniel Beauchamp
-
依托单位:
Developmental Research Program
-
批准号:10443616
-
项目类别:
-
资助金额:$9.56万
-
财政年份:2019
-
负责人:Robert Daniel Beauchamp
-
依托单位:
SMAD4 regulation of colon epithelial cell inflammatory responses
-
批准号:10192679
-
项目类别:
-
资助金额:$68.61万
-
财政年份:2019
-
负责人:Robert Daniel Beauchamp
-
依托单位:
Project 3: Targeting MYC in CRC
-
批准号:10218111
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2019
-
负责人:Robert Daniel Beauchamp
-
依托单位:
Developmental Research Program
-
批准号:10700860
-
项目类别:
-
资助金额:$9.56万
-
财政年份:2019
-
负责人:Robert Daniel Beauchamp
-
依托单位:
Integrative prediction models for metastasis risk in colon cancer
-
批准号:9213912
-
项目类别:
-
资助金额:$46.28万
-
财政年份:2016
-
负责人:Robert Daniel Beauchamp
-
依托单位:
Integrative prediction models for metastasis risk in colon cancer
-
批准号:8706083
-
项目类别:
-
资助金额:$44.89万
-
财政年份:2012
-
负责人:Robert Daniel Beauchamp
-
依托单位:
Integrative prediction models for metastasis risk in colon cancer
-
批准号:8876370
-
项目类别:
-
资助金额:$46.28万
-
财政年份:2012
-
负责人:Robert Daniel Beauchamp
-
依托单位:
Integrative prediction models for metastasis risk in colon cancer
-
批准号:8235376
-
项目类别:
-
资助金额:$46.9万
-
财政年份:2012
-
负责人:Robert Daniel Beauchamp
-
依托单位:
Integrative prediction models for metastasis risk in colon cancer
-
批准号:8517624
-
项目类别:
-
资助金额:$43.7万
-
财政年份:2012
-
负责人:Robert Daniel Beauchamp
-
依托单位:
Systems Approach to the Biological Basis of Colon Cancer Metastases
-
批准号:8091268
-
项目类别:
-
资助金额:$38.22万
-
财政年份:2009
-
负责人:Robert Daniel Beauchamp
-
依托单位:
Systems Approach to the Biological Basis of Colon Cancer Metastases
-
批准号:8294651
-
项目类别:
-
资助金额:$38.22万
-
财政年份:2009
-
负责人:Robert Daniel Beauchamp
-
依托单位:
Systems Approach to the Biological Basis of Colon Cancer Metastases
-
批准号:7916590
-
项目类别:
-
资助金额:$38.36万
-
财政年份:2009
-
负责人:Robert Daniel Beauchamp
-
依托单位:
Regulation of Gut Epithelial Cell Proliferation
-
批准号:7122603
-
项目类别:
-
资助金额:$5.83万
-
财政年份:2005
-
负责人:Robert Daniel Beauchamp
-
依托单位:
Molecular Markers for CRC Recurrence
-
批准号:8343643
-
项目类别:
-
资助金额:$21.38万
-
财政年份:2002
-
负责人:Robert Daniel Beauchamp
-
依托单位:
Molecular Markers for CRC Recurrence
-
批准号:8867156
-
项目类别:
-
资助金额:$27.58万
-
财政年份:2002
-
负责人:Robert Daniel Beauchamp
-
依托单位:
Molecular Markers for CRC Recurrence
-
批准号:8726909
-
项目类别:
-
资助金额:$17.54万
-
财政年份:2002
-
负责人:Robert Daniel Beauchamp
-
依托单位:
Molecular Markers for CRC Recurrence
-
批准号:8557697
-
项目类别:
-
资助金额:$18.67万
-
财政年份:2002
-
负责人:Robert Daniel Beauchamp
-
依托单位:
Cyclooxygenase-2 and TGF-beta Interactions in Intestinal Neoplasia
-
批准号:6563911
-
项目类别:
-
资助金额:$19.71万
-
财政年份:2002
-
负责人:Robert Daniel Beauchamp
-
依托单位:
Cyclooxygenase-2 and TGF-beta Interactions in Intestinal Neoplasia
-
批准号:6416239
-
项目类别:
-
资助金额:$19.71万
-
财政年份:2001
-
负责人:Robert Daniel Beauchamp
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: